THANK YOU FOR SUBSCRIBING


Mohan Uttarwar, CEOFocusing on academia and pharmaceutical companies in translational research, Uttarwar offers iCore: a cloud-based, mobile-enabled, informatics and analytics platform for I-O. “The industry is at a very interesting tipping point,” he says. “With the advent of immuno cancer therapy, oncology research is going through a paradigm shift, and the convergence of innovation in science, technology, and business models will transform the field in the near future.” Immuno cancer therapy bypasses the side effects that patients face as they undergo chemotherapy. While traditional cancer treatments are administered externally, I-O focuses on training the body to fight the disease internally, at a cellular level. “This was a fundamental breakthrough in biology and in understanding the immune system. Subsequently, we also witnessed major computational technology breakthroughs and implemented those in our solutions,” states Uttarwar.
iNDX Technology’s iCore platform leverages machine learning (ML), natural language processing (NLP), and cloud computing to help researchers consolidate and organize the massive amount of structured and unstructured data in the field.
Team iNDX understands the criticality of collaboration and its advantages in the field of cancer research and has, therefore, designed its platform to support collaboration over multiple devices and systems across various institutions. For instance, iNDX’s iCore platform empowered PICI Console for researchers at the Parker Institute for Cancer Immunotherapy (PICI) and its collaborators such as Stanford, UCSF, UCLA, Sloan Kettering, UPENN and MD Anderson (with Nobel Prize winner, Dr. Jim Alison). The iCore platform empowered the study teams to monitor the patients’ health in clinical trials from a sample-centric perspective across the broad ecosystem of laboratories, sites, and biobanks. With the vision to continually bolster cancer research, the company is prepared to support all collaborative efforts for the same. “We, as a team of physicians, scientists, engineers, and entrepreneurs, with over 100 years of combined experience, transitioned from diagnostic to translational research to focus completely on helping researchers find a cure for cancer.” Having aided researchers in academia as well as industry, iNDX Technology is dedicated to delving deeper into the realm of biology and technology to find the perfect intersection between the two.![]()
With the advent of immuno cancer therapy, oncology research is going through a paradigm shift, and the convergence of innovation in science, technology, and business models will transform the field in the near future
Company
iNDX Technology, Inc
Management
Mohan Uttarwar, CEO
Description
Offers a cloud-based, mobile-enabled, informatics and analytics platform for immuno oncology